Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 16, 1998

View Archived Issues

Novalon signs research agreement with Millennium

Axis Genetics and Biomira collaborate on the development of a cancer vaccine

Protein Design Labs grants patent license to Genentech

Medarex and Novartis licensing agreement for HuMAb-Mouse technology

Nonantimicrobial tetracycline exerts antiarthritic effects via upregulation of IL-10 production

rHuIL-4 safe in patients with RA; efficacy studies are indicated

HIT study confirms the benefits of raising HDL cholesterol levels

Boston Life Sciences presents amiprilose phase III data at ACR meeting

Preclinical studies indicate OP-1 is effective three days after stroke

Anti-FIX/IXa antibody prevents thrombus formation in rat model

Celecoxib studies continue to generate impressive efficacy and safety data

Prolifix and Chugai extend research collaboration

TheraTech achieves targeted delivery of doxorubicin to inflammatory sites in mice with CIA

More news from AHA: azimilide prevents atrial fibrillation

Antiulcer tetrahydropyrido compounds in development at Byk Gulden

Na+/Ca2+ exchange inhibitors patented by Taisho

New prostaglandins with IOP-lowering effects disclosed by Santen and Asahi Glass

New thrombin inhibitors from Merck & Co. for thromboembolic disorders

Novel Astra compounds inhibit mast cell, neutrophil and eosinophil activation

Novel aldose reductase inhibitor produced by Corynebacterium

Data presented at AASLD indicate role for caspase inhibitors in liver transplantation

Oxigene initiates phase I clinical trials of combretastatin

Grape-derived polyphenol inhibits HepG2 cell invasion in vitro; shows potential in HCC

Pegylated interferon proves superior to standard interferon for treatment of HCV

BTG to commercialize new approach to bacterial vaccines

Selective 5-HT7 receptor antagonist affects circadian rhythms in animal models

RJR-2403: CNS-selective nicotinic agonist with long-lasting beneficial effects on cognition

Ono-1603 compared to tacrine for protection against age-induced neuronal apoptosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...